PAHC FY 2025 Earnings Report — Phibro Animal Health Corporation Revenue & Financial Results | Market Cap Arena

Phibro Animal Health CorporationPAHC

FY 2025 Earnings

Reported August 27, 2025

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2025	Prior Q	FY 2024	QoQ Change	YoY Change
Revenue	$1.3B	—	$1.0B	—	27.4%
Op. Income	$110M	—	$53M	—	107.2%
Gross Margin	30.9%	—	30.8%	—	0.1pp
Net Margin	3.7%	—	0.2%	—	3.5pp
EPS (Diluted)	$1.19	—	$0.06	—	1883.3%
Free Cash Flow	$42M	—	$46M	—	-9.8%

Revenue Flow

Item	Amount
REVENUE	$1.3B
Cost of Revenue	$896M
GROSS PROFIT	$400M
R&D Expenses	$0
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$289M
Other Expenses	$0
Operating Expenses	$289M
Cost & Expenses	$1.2B
OPERATING INCOME	$110M
Interest Income	$3M
Interest Expense	$33M
Other Income/Expenses	-$42M
INCOME BEFORE TAX	$68M
Income Tax Expense	$20M
Net Income from Continuing Ops	$48M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$48M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$48M
D&A	$46M
EBIT	$101M
EBITDA	$147M
EPS	$1
EPS Diluted	$1

Income Statement

Item	Amount
REVENUE	$1.3B
Cost of Revenue	$896M
GROSS PROFIT	$400M
R&D Expenses	$0
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$289M
Other Expenses	$0
Operating Expenses	$289M
Cost & Expenses	$1.2B
OPERATING INCOME	$110M
Interest Income	$3M
Interest Expense	$33M
Other Income/Expenses	-$42M
INCOME BEFORE TAX	$68M
Income Tax Expense	$20M
Net Income from Continuing Ops	$48M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$48M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$48M
D&A	$46M
EBIT	$101M
EBITDA	$147M
EPS	$1
EPS Diluted	$1

Cash Flow Statement

Item	Amount
Net Income	$48M
Depreciation & Amortization	$46M
Stock-Based Compensation	$717.0K
Deferred Income Tax	-$5M
Other Non-Cash Items	$12M
Change in Working Capital	-$22M
OPERATING CASH FLOW	$80M
Capital Expenditure	-$38M
Acquisitions (Net)	-$287M
Purchases of Investments	-$14M
Sales/Maturities of Investments	$49M
Other Investing Activities	$1M
NET CASH FROM INVESTING	-$289M
Net Debt Issuance	$236M
Common Stock Repurchased	$0
Common Dividends Paid	-$19M
Other Financing Activities	-$9M
NET CASH FROM FINANCING	$207M
FREE CASH FLOW	$42M
Net Change in Cash	-$3M

Balance Sheet

Item	Amount
Cash & Equivalents	$68M
Short-Term Investments	$9M
Net Receivables	$228M
Inventory	$444M
Other Current Assets	$61M
TOTAL CURRENT ASSETS	$811M
PP&E (Net)	$396M
Goodwill	$60M
Intangible Assets	$36M
Long-Term Investments	$12M
Tax Assets	$26M
Other Non-Current Assets	$21M
TOTAL NON-CURRENT ASSETS	$550M
TOTAL ASSETS	$1.4B
Account Payables	$138M
Short-Term Debt	$16M
Deferred Revenue	$0
Other Current Liabilities	$83M
TOTAL CURRENT LIABILITIES	$293M
Long-Term Debt	$702M
Deferred Revenue NC	$0
Deferred Tax Liabilities	$19M
Other Non-Current Liabilities	$26M
TOTAL NON-CURRENT LIABILITIES	$782M
TOTAL LIABILITIES	$1.1B
Common Stock	$4.0K
Additional Paid-In Capital	$137M
Retained Earnings	$273M
Treasury Stock	$0
Accum. Other Comp. Income	-$124M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$286M
Minority Interest	$0
TOTAL EQUITY	$286M
TOTAL LIABILITIES & EQUITY	$1.4B
Total Debt	$762M
Net Debt	$694M